Phase 1B, randomized, double‐blind, dose‐escalation trial of CPG 10101 in patients with chronic hepatitis C virus

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|46|5|1341-1349

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.46, Iss.5, 2007-11, pp. : 1341-1349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of functional constipation with the Yun‐chang capsule: A double‐blind, randomized, placebo‐controlled, dose‐escalation trial

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 487-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized, Double‐Blind, Dose‐Escalation Trial of Triptorelin for Ovary Protection in Childhood‐Onset Systemic Lupus Erythematosus

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 5, 2015-05 ,pp. : 1377-1385

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 767-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase 2a randomized, double‐blind, placebo‐controlled, sequential dose‐escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate‐to‐severe psoriasis

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 767-776

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1037-1046

John Wiley & Sons Inc

Access to resources Recommend Favorite